U.S. FDA Issues Third COVID-19 Vaccine Authorization

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third experimental vaccine for the prevention of COVID-19. The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.

“The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” commented Acting FDA Commissioner Janet Woodcock, M.D., in a press statement.

The FDA had previously issued EUA for the Pfizer-BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine.

Overall, there are eleven COVID-19 vaccines being distributed globally.